Amide derivatives as glycogen synthase kinase 3-beta inhibitors

Details for Australian Patent Application No. 2002363174 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Mercken, Marc Hubert; Heeres, Jan; Buijnsters, Peter Jacobus Johannes Antonius; Nuydens, Rony Maria; De Jonge, Marc Rene; Lacrampe, Jean Fernand Armand; Freyne, Eddy Jean Edgard; Geerts, Hugo Alfons Gabriel; Koymans, Lucien Maria Henricus; Embrechts, Werner Constant Johan; Janssen, Paul Adriaan Jan; Daeyaert, Frederik Frans Desire; Ludovici, Donald William; Willems, Marc; Lewi, Paulus Joannes; Kukla, Michael Joseph

Agent Shelston IP

Pub. Number AU-B-2002363174

PCT Number PCT/EP02/12067

PCT Pub. Number WO2003/037869

Priority 01204193.5 01.11.01 EP

Filing date 29 October 2002

Wipo publication date 12 May 2003

Acceptance publication date 25 September 2008

International Classifications

C07D 213/82 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

5 June 2003 Complete Application Filed

  Priority application(s): 01204193.5 01.11.01 EP

10 July 2003 Application Open to Public Inspection

  Published as AU-B-2002363174

25 September 2008 Application Accepted

  Published as AU-B-2002363174

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002363175-MNK KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM

2002363173-New bacterium causing poultry disease and vaccine derived thereof